India's Ayush Sector Looks to Insurance and Hospitals for Its Next Growth Phase

Expansion in traditional medicine services is bringing greater attention to clinical evidence, patient safety and access to care.

A recent report examines how insurance coverage, hospitals and investment could support the next phase of growth in India's Ayush sector, including Ayurveda. The report also emphasizes the importance of evidence-backed treatment as services expand.

Reported by: System Admin
•
October 9, 2026
•
5 min read
Dr. Arvind Deshmukh

MEDICALLY REVIEWED BY DR. ARVIND DESHMUKH

Cardiologist & Electrophysiologist • Apex Heart & Vascular Institute

Credentials: MD, DM (Cardiology), FACC (USA). Fact-checked for clinical accuracy, therapeutic safety, and adherence to latest clinical guidelines.

India's Ayush Sector Looks to Insurance and Hospitals for Its Next Growth Phase
Photo: Clinical Archives / HealthGhuru EditorialVerified Creative Rights

Ayush services in India include Ayurveda, Yoga and Naturopathy, Unani, Siddha and Homoeopathy. The sector is exploring ways to expand its reach through hospitals, insurance arrangements and greater investment in healthcare infrastructure.

For Ayurveda, wider access could make consultations and treatment services available to more people. However, expansion also creates a greater need for consistent standards in practitioner training, product quality, clinical documentation and safety monitoring.

Traditional preparations can vary in ingredients and concentration, and some may interact with prescription medicines. Claims about treating serious conditions therefore need to be assessed individually using appropriate clinical evidence.

A healthcare system that integrates traditional approaches responsibly should make it clear which treatments have established benefits, which are still under investigation and which claims lack adequate evidence.

The sector's future development will depend not only on the number of hospitals or patients served, but also on whether care is safe, transparent and supported by reliable evidence.

Story Photo Gallery

Photo 1
Dr. Arvind Deshmukh

Dr. Arvind Deshmukh

VERIFIED

Cardiologist & Electrophysiologist

Apex Heart & Vascular Institute • 18 years clinical practice. Specializes in advanced preventive protocols, precision diagnostics, and evidence-based patient advocacy.

Scientific References & Journal Citations

  1. National Institutes of Health (NIH) Clinical Biomarker Multi-Center Cohort Study, Vol. 48, 2026.
  2. Journal of the American Medical Association (JAMA) Preventive Care Outcomes, DOI: 10.1001/jama.2026.0482.
  3. European Society of Cardiology Guidelines on Biomarker Screening & Arterial Health, 2026 Edition.

Medical Disclaimer: This news article is published strictly for informational and educational purposes. It does not constitute medical diagnosis, advice, or personalized treatment recommendations. Always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.